Schizophrenia and Disorders With Psychotic Features Clinical Trial
Official title:
Evaluation of Social Skills Training in Reducing Negative Symptoms in Patients With Refractory Schizophrenia
Objective Primary:
To evaluate the efficacy of social skills training in reducing negative symptoms in patients
with refractory schizophrenia, in comparison with control (befriending group).
Secondary:
To evaluate changes in social functioning.
To evaluate the effect of SST in other dimensions of psychopathology: positive symptoms,
depression and general psychopathology.
To evaluate the impact of SST in cognition.
Hypothesis Social skills training is more effective than control group (Befriending) in
reducing negative symptoms in patients with refractory schizophrenia.
In schizophrenia positive symptoms can be improved with an antipsychotic treatment. However
there is a subgroup of patients who have a predominance of persistent negative symptoms that
do not respond to antipsychotic treatment, such as blunted affect , emotional and social
withdrawal, and there is evidence that such symptoms can improve with psychosocial
interventions.
The objective of this study is to evaluate the efficacy of Social Skills Training on
negative symptoms in patients with refractory schizophrenia by means of a randomized,
single-blind controlled trial with the duration of a year, including, follow up.
This study will be conducted in two groups: one group will receive social skills training
(N=46) and a control group (N=46) will attend the same number of sessions, but without
intervention of the therapists (befriending).
Psychiatric, psychological and neuropsychological aspects will be evaluated at baseline,
after 20 weeks and 6 months after the end of the intervention.
The scales that will be used for the psychiatric assessments are: PANSS (reduction of 20% in
the negative subscale), CGI, CALGARY, SDS, and PSP, As well as the Social Skills Inventory
IHS. The neuropsychological assessment will have groups of scales to measure: Attention,
Memory, Executive Functions, Estimated Intellectual Efficiency and a ToM. For statistical ,
the repeated measure ANOVA will be used, as well as the effect size and number needed to
treat.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01196858 -
Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland
|
N/A | |
Completed |
NCT00136760 -
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
|
Phase 2 | |
Completed |
NCT03309475 -
Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AGES-Mind)
|
N/A | |
Not yet recruiting |
NCT01968161 -
Investigator Initiated Study - Asenapine Early Psychosis
|
Phase 4 | |
Completed |
NCT00135772 -
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
|
N/A | |
Completed |
NCT02308462 -
Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents
|
N/A | |
Completed |
NCT03133143 -
Video Games Among People With Schizophrenia
|
N/A | |
Completed |
NCT00309452 -
Specialized Treatment Early in Psychosis (STEP)
|
N/A | |
Not yet recruiting |
NCT02240173 -
Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia
|
Phase 1/Phase 2 | |
Completed |
NCT00218218 -
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
|
Phase 2 | |
Completed |
NCT02321943 -
Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study
|
N/A | |
Completed |
NCT02928965 -
The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms
|
Phase 2 | |
Completed |
NCT02307396 -
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
|
Phase 4 | |
Terminated |
NCT00748566 -
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
|
Phase 4 | |
Completed |
NCT00363181 -
Side Effects of Antipsychotic Medications
|
||
Completed |
NCT00137189 -
Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation
|
N/A |